Back to News
Market Impact: 0.25

Detailed Fundamental Analysis

IWMNDAQ
Company FundamentalsAnalyst InsightsHealthcare & Biotech
Detailed Fundamental Analysis

A fundamental report on the iShares Russell 2000 ETF (IWM), a Small-Cap Value ETF, details its factor exposures and portfolio composition. IWM exhibits a Value score of 55, Momentum of 33, Quality of 10, and Low Volatility of 13, highlighting its strong value tilt and lower exposure to quality and low volatility factors. The ETF's largest sector exposure is Services, with Biotechnology & Drugs as its leading industry.

Analysis

The iShares Russell 2000 ETF (IWM) is fundamentally positioned as a Small-Cap Value ETF, exhibiting a notable Value factor score of 55. This strong value tilt is contrasted by significantly lower exposures to Quality (10) and Low Volatility (13) factors, indicating a strategic focus on potentially undervalued small-cap companies that may carry higher inherent risk. The ETF's portfolio composition reveals a primary allocation to the Services sector, with a specific concentration in the Biotechnology & Drugs industry. This sector and industry focus suggests a targeted approach within the small-cap value universe, potentially exposing investors to the unique growth drivers and regulatory risks associated with the healthcare innovation space. The low Quality and Low Volatility scores imply that IWM's underlying holdings may exhibit greater earnings variability and higher price sensitivity. While its Momentum score of 33 suggests some exposure to recent price trends, it is not a dominant factor, reinforcing the ETF's core value-driven investment philosophy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWM0.00
NDAQ0.00

Key Decisions for Investors

  • Investors should consider IWM for strategic small-cap value exposure, acknowledging its pronounced tilt towards value and lower quality/volatility characteristics.
  • Monitor the performance and regulatory developments within the Services and Biotechnology & Drugs sectors, given their significant weighting in the ETF.
  • Evaluate IWM's fit within a broader portfolio, especially for those seeking a higher-risk, value-driven small-cap allocation.